Lucid Diagnostics Inc. (LUCD)
USD 1.5
(-0.33%)
USD 1.5
(-0.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 27.27 Million USD | -16.12% |
| 2022 | 32.5 Million USD | -44.9% |
| 2021 | 58.99 Million USD | 2588.03% |
| 2020 | 2.19 Million USD | 112.29% |
| 2019 | 1.03 Million USD | 5708.43% |
| 2018 | 17.8 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 32.04 Million USD | 17.52% |
| 2024 Q2 | 34.11 Million USD | 6.44% |
| 2023 Q4 | 27.27 Million USD | -17.97% |
| 2023 Q3 | 33.24 Million USD | -21.75% |
| 2023 FY | 27.27 Million USD | -16.12% |
| 2023 Q1 | 49.12 Million USD | 51.11% |
| 2023 Q2 | 42.48 Million USD | -13.51% |
| 2022 Q4 | 32.5 Million USD | -15.29% |
| 2022 Q3 | 38.37 Million USD | -15.47% |
| 2022 FY | 32.5 Million USD | -44.9% |
| 2022 Q2 | 45.4 Million USD | -26.84% |
| 2022 Q1 | 62.06 Million USD | 5.19% |
| 2021 Q1 | 2.07 Million USD | -5.57% |
| 2021 FY | 58.99 Million USD | 2588.03% |
| 2021 Q4 | 58.99 Million USD | 1689.85% |
| 2021 Q3 | 3.29 Million USD | -31.86% |
| 2021 Q2 | 4.83 Million USD | 133.41% |
| 2020 Q4 | 2.19 Million USD | 0.0% |
| 2020 FY | 2.19 Million USD | 112.29% |
| 2019 FY | 1.03 Million USD | 5708.43% |
| 2018 FY | 17.8 Thousand USD | 0.0% |
| 2018 Q4 | 17.8 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 13.059% |
| BrainsWay Ltd. | 62.97 Million USD | 56.695% |
| Cerus Corporation | 197.74 Million USD | 86.21% |
| Envoy Medical, Inc. | 7.64 Million USD | -256.937% |
| electroCore, Inc. | 16.38 Million USD | -66.412% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -254.524% |
| IceCure Medical Ltd | 16.41 Million USD | -66.179% |
| Inogen, Inc. | 326.19 Million USD | 91.64% |
| OrthoPediatrics Corp. | 449.58 Million USD | 93.934% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -64.485% |
| MaxCyte, Inc. | 268.27 Million USD | 89.835% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -236.778% |
| Nexalin Technology, Inc. | 3.63 Million USD | -650.843% |
| Orthofix Medical Inc. | 925.31 Million USD | 97.053% |
| PAVmed Inc | 33.11 Million USD | 17.661% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 80.99% |
| RxSight, Inc. | 182.55 Million USD | 85.062% |
| Sight Sciences, Inc. | 166.65 Million USD | 83.636% |
| SI-BONE, Inc. | 230.42 Million USD | 88.165% |
| TELA Bio, Inc. | 78.04 Million USD | 65.06% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 89.175% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -154.147% |
| Acutus Medical, Inc. | 53.96 Million USD | 49.463% |
| Talis Biomedical Corporation | 98.34 Million USD | 72.27% |
| Spectral AI, Inc. | 10.69 Million USD | -155.051% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 87.528% |
| CVRx, Inc. | 115.22 Million USD | 76.334% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 53.513% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -775.37% |
| Bioventus Inc. | 810.91 Million USD | 96.637% |
| Venus Concept Inc. | 93.65 Million USD | 70.882% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -6.006% |
| LivaNova PLC | 2.42 Billion USD | 98.878% |
| 908 Devices Inc. | 202.98 Million USD | 86.565% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 96.613% |
| Nemaura Medical Inc. | 14.56 Million USD | -87.252% |
| NeuroPace, Inc. | 107.65 Million USD | 74.668% |
| LENSAR, Inc. | 69.58 Million USD | 60.811% |
| Apyx Medical Corporation | 79.24 Million USD | 65.586% |
| Cutera, Inc. | 346.29 Million USD | 92.125% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 35.096% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1416.685% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 89.924% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 36.077% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.279% |
| Axonics, Inc. | 719.92 Million USD | 96.212% |
| Outset Medical, Inc. | 313.8 Million USD | 91.31% |
| IRIDEX Corporation | 34.43 Million USD | 20.81% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 93.262% |
| IRadimed Corporation | 92.15 Million USD | 70.409% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -419.033% |
| INVO Bioscience, Inc. | 20.88 Million USD | -30.555% |
| Telesis Bio, Inc. | 70.41 Million USD | 61.27% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 82.304% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.818% |
| Quipt Home Medical Corp. | 247.4 Million USD | 88.978% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -192.911% |
| Pulmonx Corporation | 178.95 Million USD | 84.761% |
| Dynatronics Corporation | 25.94 Million USD | -5.125% |
| Modular Medical, Inc. | 13.8 Million USD | -97.509% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -154.218% |
| Semler Scientific, Inc. | 78.06 Million USD | 65.068% |
| InMode Ltd. | 863.28 Million USD | 96.841% |
| Bruker Corporation | 4.24 Billion USD | 99.358% |
| Cytosorbents Corporation | 53.26 Million USD | 48.799% |
| DexCom, Inc. | 6.26 Billion USD | 99.565% |
| Align Technology, Inc. | 6.08 Billion USD | 99.552% |
| Viveve Medical, Inc. | 25.91 Million USD | -5.237% |
| ZimVie Inc. | 1.2 Billion USD | 97.738% |
| Movano Inc. | 9.42 Million USD | -189.46% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 94.52% |
| Nexalin Technology, Inc. | 3.63 Million USD | -650.843% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 53.513% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 97.137% |
| Profound Medical Corp. | 43.68 Million USD | 37.578% |
| Insulet Corporation | 2.58 Billion USD | 98.946% |
| enVVeno Medical Corporation | 48.63 Million USD | 43.929% |
| Surmodics, Inc. | 185.73 Million USD | 85.318% |
| iCAD, Inc. | 41.41 Million USD | 34.159% |
| Nuwellis, Inc. | 9.77 Million USD | -179.12% |
| Biotricity, Inc. | 5.94 Million USD | -358.888% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 93.704% |
| Aethlon Medical, Inc. | 8.24 Million USD | -230.707% |
| InspireMD, Inc. | 47.64 Million USD | 42.762% |
| PAVmed Inc. | 33.11 Million USD | 17.661% |
| BIOLASE, Inc. | 35.1 Million USD | 22.31% |
| Beyond Air, Inc. | 56.96 Million USD | 52.125% |
| FONAR Corporation | 214.24 Million USD | 87.272% |
| AxoGen, Inc. | 196.82 Million USD | 86.145% |
| Vivani Medical, Inc. | 45.79 Million USD | 40.455% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 90.31% |
| Inari Medical, Inc. | 674.23 Million USD | 95.955% |
| UFP Technologies, Inc. | 404.13 Million USD | 93.252% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -16.546% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -186.959% |
| Tenon Medical, Inc. | 6.34 Million USD | -329.787% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -189.891% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 73.69% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.41% |
| Sintx Technologies, Inc. | 15.36 Million USD | -77.481% |
| NanoVibronix, Inc. | 6.67 Million USD | -308.601% |
| Quanterix Corporation | 425.01 Million USD | 93.584% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -192.911% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 49.243% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.438% |
| TransMedics Group, Inc. | 706.04 Million USD | 96.138% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 56.846% |
| NeuroMetrix, Inc. | 21.42 Million USD | -27.285% |
| Hyperfine, Inc. | 94.19 Million USD | 71.051% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 89.849% |
| Biomerica, Inc. | 9.25 Million USD | -194.683% |
| Bone Biologics Corporation | 3.73 Million USD | -629.581% |
| AVITA Medical, Inc. | 144.33 Million USD | 81.107% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -460.128% |
| Silk Road Medical, Inc | 265.3 Million USD | 89.721% |